Celestial Biolabs (Delisted) share news and announcements
BSE: 532871Pharmaceuticals & Biotechnology
Formerly Celestial Labs
Last traded ₹1.75 on 11 Mar 2020
Delisted on 16 Oct 2024.
Celestial Biolabs board meetings
139 filed, newest first. Page 3 of 3.
Jan 2014
9 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 09, 2014, have transacted the following business: 1. To convene ....9 Jan · Board meeting
Nov 2013
6 Nov · Board meeting
To consider and take on record the Un - audited financial results of the Company for the quarter/half year ended September 30, 2013.
Aug 2013
6 Aug · Board meeting
Meeting of the Board of Directors and Audit Committee of the Company is schedule to be held on August 14, 2013:- 1) To consider and take on record the un-audited financial results of the Company for the quarter ended June 30, 2013; 2) To decide date, time and venue of the Annual General Meeting and the book closure dates.
May 2013
21 May · Board meeting
To consider and take on record the audited financial results of the Company for the quarter/year ended March 31, 2013.
Feb 2013
1 Feb · Board meeting
Meeting of the Board of Directors and Audit Committee of the Company is schedule to be held on 11.02.2013 to consider and take on record the un-audited financial results of the Company for the quarter ended 31.12.2012.
Sep 2012
3 Sep · Board meeting
Board of Directors of the Company at its meeting held on September 03, 2012, inter alia : 1. Have accepted the resignation of Dr. ....3 Sep · Board meeting
Board of Directors in the Board meeting held on September 03, 2012:(a) Have accepted the resignation of Dr D C Sastry as the Chairman and Director of the company with immediate effect.(b) Have appointed Dr A N Singh as the Chairman of the Company.(c) Have reconstituted the Audit Committee, Remuneration Committee and the Shareholders Grievance committee consequent to resignation of Dr D C Sastry.
Aug 2012
3 Aug · Board meeting
To consider and take on the record the unaudited financial results of the Company for the quarter ended June 30, 2012
May 2012
22 May · Board meeting
Meeting of the Board of Directors and Audit Committee of the Company is scheduled to be held on May 30, 2012 to consider and take on record the audited financial results of the Company for the financial year ended March 31, 2012.
Jan 2012
25 Jan · Board meeting
Meeting of the Board of Directors and Audit Committee of the Company is scheduled to be held on February 03, 2012 to consider and take on record the un-audited financial results of the Company for the quarter ended December 31, 2011.
Nov 2011
8 Nov · Board meeting
Meeting of the Board of Directors and Audit Committee of the Company is scheduled to be held on November 14, 2011 to consider and take on record the un-audited financial results of the Company for the quarter ended September 30, 2011.
Aug 2011
8 Aug · Board meeting
Meeting of the Board of Directors and Audit Committee of the Company is scheduled to be held on August 12, 2011 to consider the following : (1) To consider and take on record the un-audited financial results of the Company for the quarter ended June 30, 2011; and (2) To consider the audited financial results for the Financial year ended March 31, 2011.
May 2011
10 May · Board meeting
(1) To consider and take on record the unaudited financial results of the Company for the quarter ended March 31, 2011; (2) To consider the Limited review report given by the statutory auditor of the Company.
Apr 2011
8 Apr · Board meeting
Board of Directors of the Company at its meeting held on April 05, 2011, inter alia, has transacted the following: 1. Dr. A. N. Singh ....8 Apr · Board meeting
Outcome of the meeting of the Board of Directors is as follows : (1) Dr. A. N. Singh has proposed, subject to all necessary approvals, to renounce his entitlement of Sweat Equity Shares for the balance consideration amount of Rs.4.91 crores (towards the transfer of IPRs developed and owned by him to the Company) which is 60% (approx) of his total entitlement of Rs.8.17 crores; (2) To convene an Extraordinary General Meeting of the Company on April 28, 2011 to consider the following : (a) To obtain the consent of the shareholders, subject to necessary approvals, if any, from various regulatory agencies, for allotment of the Equity Shares of the Company, renounced by Dr. A. N. Singh, the Promoter of the Company to the shareholders (other than Promoter Group) and the employees of the company, without any consideration, (b) To fill the casual vacancy caused in the office of the statutory auditor of the Company by resignation of M/s. G.V.Rao & Co., the then existing Statutory Auditor.
Feb 2011
14 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 14, 2011, inter alia, has transacted the following: 1. Allotment ....
Jan 2011
31 Jan · Board meeting
To consider and take on record the un-audited financial results of the Company for the quarter ended December 31, 2010 and to convert the warrants into equity shares.
Nov 2010
2 Nov · Board meeting
To consider and take on record the un-audited financial results of the Company for the quarter ended September 30, 2010.
Aug 2010
2 Aug · Board meeting
To consider the following: 1) To consider and take on record the un-audited financial results of the Company for the quarter ended June 30, 2010 and 2) To consider the audited financial results for the Financial year ended March 31, 2010.
May 2010
3 May · Board meeting
To consider the following: (1) To consider and take on record the Un-audited financial results of the Company for the quarter ended March 31, 2010 and (2) To allot 6,20,000 sweat equity shares to Dr. A.N. Singh, Chairman and Managing Director of the Company provided the approvals from the stock Exchanges are received prior to the date of the said Board meeting.
Feb 2010
26 Feb · Board meeting
Vide its letter dated February 26, 2010 that "The Board of Directors in their just concluded Board meeting held today have allotted 5,89,000 equity shares of Rs.10/- each as Sweat Equity Shares to Dr A N Singh, Chairman and Managing Director of the Company in lieu of compensation(part) for transfer of Intellectual property rights in accordance with SEBI Guidelines".26 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 26, 2010, has allotted 5,89,000 equity shares of Rs. 10/- each as Sweat Equity ....18 Feb · Board meeting
To consider the allotment of 5,89,000 sweat equity shares to Dr. A N Singh, Chairman and Managing Director of the Company in lieu of compensation (part) for transfer of Intellectual property rights.
Jan 2010
27 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 25, 2010, have transacted the following business: (1) Allotment of 22,00,000 warrants convertible into equity shares within a period of 18 months at a price of Rs.27/- per warrant in accordance with SEBI Guidelines.25 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 25, 2010, inter alia, have make allotment of 22,00,000 warrants convertible ....13 Jan · Board meeting
To consider the following: (1) To consider and take on record the Un-audited financial results of the Company for the quarter ended December 31, 2009 and (2) To allot 22,00,000 warrants to non promoters group. (3) To allot 5,89,000 sweat equity shares to Dr.A.N. Singh, Chairman and Managing Director of the Company provided the approvals from the stock Exchanges are received prior to the date of the said Board meeting.
Nov 2009
6 Nov · Board meeting
Outcome of the meeting of the Board of Directors held on November 06, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2009
30 Oct · Board meeting
Board of Directors in their Board Meeting held on October 30, 2009 have transacted the following business : 1) To meet the financial requirements with regard to the expansion plans of the company, the Board has decided to make preferential issue upto 30,00,000 equity shares to Non Promoter/ Others subject to the approval of shareholders and other regulatory bodies. 2) To convene an Extraordinary General Meeting of the members for obtaining their consent for a) Changing the name of the Company from "Celestial Labs Limited" to "Celestial Biolabs Labs Limited" and b) Preferential issue upto 30,00,000 equity shares to non promoter/others.23 Oct · Board meeting
To consider the following: 1) To consider and take on record the un-audited financial results of the Company for the quarter ended September 30, 2009 and 2) To consider the proposal of preferential issue of equity shares to non promoter group.
Jul 2009
23 Jul · Board meeting
To consider the following:- 1) To consider and take on record the un-audited financial results of the Company for the quarter ended June 30,2009 and 2) To consider the audited financial results for the Financial year ended March 31, 2009.
Apr 2009
17 Apr · Board meeting
Meeting of the Board of Directors and Audit Committee of the Company is scheduled to be held on April 27, 2009 to consider the un-audited financial results of the Company for the quarter ended March 31, 2009.
Jan 2009
23 Jan · Board meeting
Meeting on 30 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Oct 2008
8 Oct · Board meeting
To consider and inter-alia approve, unaudited financial results for the quarter ended on September 30, 2008.
Jul 2008
8 Jul · Board meeting
To consider and inter-alia approve, the audited financial results for the year ended March 31, 2008, un-audited financial results for the quarter ended on June 30, 2008 and issue of preferential allotment to promoters in lieu IPR and recommendation of dividend, if any, for the financial year 2007-2008.
Apr 2008
15 Apr · Board meeting
Meeting on 28 Apr 2008: “Unaudited Financial Results for the qtr ended March 31, 2008”
Dec 2007
20 Dec · Board meeting
Meeting on 2 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”
Oct 2007
17 Oct · Board meeting
Meeting on 26 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”